AB5716
Anti-Hey 2/HRT2 Antibody
Chemicon®, from rabbit
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
IHC
Citations:
7
biological source
rabbit
Quality Level
conjugate
unconjugated
antibody form
affinity purified immunoglobulin
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
human, mouse
manufacturer/tradename
Chemicon®
technique(s)
immunohistochemistry: suitable
NCBI accession no.
UniProt accession no.
shipped in
dry ice
target post-translational modification
unmodified
Gene Information
human ... HEY2(23493)
Immunogen
Synthetic peptide, amino acids 314-330 of human Hey 2 / HRT2.
Application
Anti-Hey 2/HRT2 Antibody is an antibody against Hey 2/HRT2 for use in IH.
Biochem/physiol Actions
Recognizes Hey 2 / HRT2, a Helix-loop-helix class of transcription factor.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Try our Product Selector Tool to narrow your options
Storage Class
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Expression of HES and HEY genes in infantile hemangiomas.
Adepoju, O; Wong, A; Kitajewski, A; Tong, K; Boscolo, E; Bischoff, J; Kitajewski, J; Wu, JK
Vascular Cell null
Sameer H Halani et al.
NPJ precision oncology, 2, 24-24 (2018-11-13)
Oligodendrogliomas are diffusely infiltrative gliomas defined by IDH-mutation and co-deletion of 1p/19q. They have highly variable clinical courses, with survivals ranging from 6 months to over 20 years, but little is known regarding the pathways involved with their progression or
Madhumita Basu et al.
JCI insight, 2(20) (2017-10-20)
Birth defects are the leading cause of infant mortality, and they are caused by a combination of genetic and environmental factors. Environmental risk factors may contribute to birth defects in genetically susceptible infants by altering critical molecular pathways during embryogenesis
Global Trade Item Number
| SKU | GTIN |
|---|---|
| AB5716 | 04053252271908 |